Earnings History Data for Gemini Therapeutics, Inc. (GMTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Gemini Therapeutics, Inc.
Gemini Therapeutics Inc. is a clinical stage precision medicine company. It engages in developing novel therapeutic compounds to treat genetically defined age-related macular degeneration. The company's lead candidate principally includes GEM103. Its pipeline includes recombinant proteins, gene therapies and monoclonal antibodies. Gemini Therapeutics Inc., formerly known as FS Development Corp., is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10-03-2022 | PM | 7:00 AM ET (Mar 10) |
GMTX | Gemini Therapeutics | 63.00 | -0.41 | -0.50 | 0.00 | Gemini Therapeutics GAAP EPS of -$1.78 beats by $0.17 [3/10/2022 7:32 AM] |
1.48 | -0.07 (-4.52%) |
1.55 | 0.0 (0.00%) |
0.0 - 0.0 | 47,670 | 0 | 0 | |
| 15-11-2021 | PM | GMTX | Gemini Therapeutics | 147.00 | -0.43 | -0.47 | 0.00 | Gemini Therapeutics EPS beats by $0.04 [11/15/2021 7:59 AM] |
3.58 | 0.16 (4.68%) |
3.50 | 0.08 (2.34%) |
3.22 - 19.09 | 213,596 | 120,000 | 1,534 | ||